trial · primary record
JNJ-79635322
Multiple Myeloma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 168 |
| Primary completion | 2028-12-12 |
| Primary endpoint | Overall Response Rate (ORR) |
| Registry ID | NCT07266441 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:43.038Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07266441
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-79635322 · compound